Biomay is a biotech company discovering and developing innovative allergy therapeutics. Biomay is a leader in the diagnostic and therapeutic use of recombinant allergens.
Biomay is a biotech company discovering and developing innovative allergy therapeutics. Biomay is a leader in the diagnostic and therapeutic use of recombinant allergens.
XstalBio tackles challenging biologic formulations (required dosing too frequent, controlled release of API required, competitors hold blocking formulation patents, better adjuvant needed for target antigens, etc… ).